Clinical Trials
43 trialsOmega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention
City of Hope Medical Center
Window of Opportunity Study Targeting the Inflammatory Milieu
University of Colorado, Denver
VITAL
Brigham and Women's Hospital
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Memorial Sloan Kettering Cancer Center
Taxoprexin® Treatment for Advanced Eye Melanoma
American Regent, Inc.
Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract
American Regent, Inc.
Taxoprexin Treatment for Advanced Skin Melanoma
American Regent, Inc.
Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma
Affiliated Hospital of Guangdong Medical University
Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer
American Regent, Inc.
Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women With Polycystic Ovary Syndrome.
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma
American Regent, Inc.
DHA-WIN
AHS Cancer Control Alberta
Omega-3 Fatty Acids and Nutritional Support in Gastrointestinal Cancer
Maimónides Biomedical Research Institute of Córdoba
NEOMET
University of Eastern Piedmont
Hepatoprotective Measures for Children at High Risk of NAFLD
Ain Shams University
OMgObPCOS
Coordinación de Investigación en Salud, Mexico
PCOS
University of Alberta
Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis
S.L.A. Pharma AG
Perioperative Supplementation With Immunonutrition and Its Impact on Surgical Outcome and Pain in Oral Cavity or Mandibular Tumours
Cairo University
EFFORTS
Mayo Clinic
Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects
The University of Texas Health Science Center at San Antonio
Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer
Ohio State University Comprehensive Cancer Center
PROTEIN
Royal Surrey County Hospital NHS Foundation Trust
Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer
Columbia University
Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women
University of Kansas Medical Center
Docosahexaenoic Acid (DHA) To Prevent Development of Cognitive Dysfunction Due to Chemotherapy
University of Kansas Medical Center
Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids
Mayo Clinic
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors
National Cancer Institute (NCI)
Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis
Universidade Estadual Paulista Júlio de Mesquita Filho
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
Case Comprehensive Cancer Center
Omega
British Columbia Cancer Agency
Omega-3 Supplementation for Smell Dysfunction
Stanford University
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
University of Rochester
Omega-3 Supplementation in Cervix Cancer Patients Undergoing Chemoradiotherapy
Brazilian National Cancer Institute
Influence of Immune Nutrition Diet on 90-Day Outcomes in Patients Undergoing Radical Cystectomy
Mansoura University
Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer
OHSU Knight Cancer Institute
A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia
H. Lee Moffitt Cancer Center and Research Institute
DHA-ALL
Coordinación de Investigación en Salud, Mexico
An Immunonutritional Approach to the Prevention of Skin Cancer
University of Manchester
PAOPUFAGC
The First Hospital of Jilin University
EMT
University of Leeds
KLYMF
Oslo University Hospital
TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
Amarin Neuroscience Ltd